Clinical Trial Update: A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)

View source ↗

Summary

Post-marketing surveillance study in Korea evaluating Pergoveris (follitropin alfa + lutropin alfa) for infertility; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Pergoveris (follitropin alfa and lutropin alfa)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility | Status: COMPLETED | Results posted: 2019-07-19